India: Pharma M&A deals dip to 5-year low in 2017 amid tough business conditions

India: Pharma M&A deals dip to 5-year low in 2017 amid tough business conditions

Photographer: Krisztian Bocsi/Bloomberg

Isha Trivedi

17 October, 2017

Aurobindo Pharma LtdGrant Thornton Advisory Pvt. Ltd.lupinPiramal Enterprises LtdSymbiomix Therapeutics

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.